Ligand Pharmaceuticals Net Income 2006-2021 | LGND
For a detailed definition, formula and example for Net Income, check out our new background page here.
Ligand Pharmaceuticals net income from 2006 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Ligand Pharmaceuticals Annual Net Income
(Millions of US $) |
| 2020 |
$-3 |
| 2019 |
$629 |
| 2018 |
$143 |
| 2017 |
$13 |
| 2016 |
$-2 |
| 2015 |
$230 |
| 2014 |
$12 |
| 2013 |
$11 |
| 2012 |
$-1 |
| 2011 |
$10 |
| 2010 |
$-10 |
| 2009 |
$-2 |
| 2008 |
$-98 |
| 2007 |
$282 |
| 2006 |
$-32 |
| 2005 |
$-36 |
Ligand Pharmaceuticals Quarterly Net Income
(Millions of US $) |
| 2021-09-30 |
$14 |
| 2021-06-30 |
$31 |
| 2021-03-31 |
$18 |
| 2020-12-31 |
$6 |
| 2020-09-30 |
$-7 |
| 2020-06-30 |
$22 |
| 2020-03-31 |
$-24 |
| 2019-12-31 |
$-7 |
| 2019-09-30 |
$-15 |
| 2019-06-30 |
$-14 |
| 2019-03-31 |
$666 |
| 2018-12-31 |
$-42 |
| 2018-09-30 |
$67 |
| 2018-06-30 |
$73 |
| 2018-03-31 |
$45 |
| 2017-12-31 |
$-7 |
| 2017-09-30 |
$8 |
| 2017-06-30 |
$6 |
| 2017-03-31 |
$5 |
| 2016-12-31 |
$-3 |
| 2016-09-30 |
$1 |
| 2016-06-30 |
$-6 |
| 2016-03-31 |
$7 |
| 2015-12-31 |
$6 |
| 2015-09-30 |
$199 |
| 2015-06-30 |
$24 |
| 2015-03-31 |
$1 |
| 2014-12-31 |
$7 |
| 2014-09-30 |
$1 |
| 2014-06-30 |
$2 |
| 2014-03-31 |
$2 |
| 2013-12-31 |
$2 |
| 2013-09-30 |
$2 |
| 2013-06-30 |
$6 |
| 2013-03-31 |
$1 |
| 2012-12-31 |
$1 |
| 2012-09-30 |
$-0 |
| 2012-06-30 |
$-3 |
| 2012-03-31 |
$1 |
| 2011-12-31 |
$5 |
| 2011-09-30 |
$-4 |
| 2011-06-30 |
$-0 |
| 2011-03-31 |
$10 |
| 2010-12-31 |
$5 |
| 2010-09-30 |
$-12 |
| 2010-06-30 |
$-0 |
| 2010-03-31 |
$-3 |
| 2009-12-31 |
$3 |
| 2009-09-30 |
$2 |
| 2009-06-30 |
$-2 |
| 2009-03-31 |
$-5 |
| 2008-12-31 |
$-70 |
| 2008-09-30 |
$-18 |
| 2008-06-30 |
$-6 |
| 2008-03-31 |
$-4 |
| 2007-12-31 |
$6 |
| 2007-09-30 |
$1 |
| 2007-06-30 |
$0 |
| 2007-03-31 |
$274 |
| 2006-12-31 |
$141 |
| 2006-09-30 |
$-15 |
| 2006-06-30 |
$-16 |
| 2006-03-31 |
$-142 |
| 2005-12-31 |
$-3 |
| 2005-09-30 |
$-6 |
| 2005-06-30 |
$-9 |
| 2005-03-31 |
$-18 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$2.519B |
$0.186B |
|
Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.
|
